Prednisolone and flurbiprofen drops to maintain mydriasis during phacoemulsification cataract surgery

J Cataract Refract Surg. 2003 Dec;29(12):2372-7. doi: 10.1016/s0886-3350(03)00137-8.

Abstract

Purpose: To compare the effects on the pupil of pretreatment with prednisolone 1% eyedrops, flurbiprofen 0.03% eyedrops, and sodium chloride 0.9% eyedrops in patients having phacoemulsification cataract surgery.

Setting: Christopher Home Eye Unit, Royal Albert Edward Infirmary, Wigan, United Kingdom.

Methods: One hundred thirty-six white patients having phacoemulsification with no history of eye disease, antiinflammatory medication, or diabetes were enrolled in this prospective randomized double-blind study. Patients were allocated to receive flurbiprofen 0.03%, prednisolone 1%, or sodium chloride 0.9% (placebo) eyedrops at 30-minute intervals beginning 2 hours before surgery. All patients received cyclopentolate 1% and phenylephrine 2.5% drops preoperatively and epinephrine 1:10(6) intraoperatively in the intraocular irrigating solution. The pupil diameter was measured from a television screen at the preset magnification of the operating microscope immediately before the incision, at the end of nucleus emulsification, at the end of irrigation/aspiration (I/A), and at the end of surgery. One hundred twelve patients with a baseline pupil diameter of at least 6.0 mm who had uneventful phacoemulsification were analyzed.

Results: The baseline pupil diameters were statistically similar. An analysis of variance did not reveal an overall significant mydriasis-maintaining effect of prednisolone or flurbiprofen compared to the placebo at any stage of surgery (P =.16 to.37). The 95% confidence interval showed flurbiprofen to be superior to prednisolone at the end of surgery. According to the paired t test, the reduction from the baseline at the end of I/A in the prednisolone group (P =.051) and at the end of surgery in the flurbiprofen group (P =.22) was not significant.

Conclusion: In the presence of epinephrine in the intraocular irrigating solution, both prednisolone 1% and flurbiprofen 0.03% failed to maintain mydriasis at the crucial steps of nuclear emulsification and cortical I/A.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Aged
  • Cyclooxygenase Inhibitors / administration & dosage*
  • Double-Blind Method
  • Drug Evaluation
  • Female
  • Flurbiprofen / administration & dosage*
  • Glucocorticoids / administration & dosage*
  • Humans
  • Lens Implantation, Intraocular
  • Male
  • Mydriatics / administration & dosage
  • Ophthalmic Solutions / administration & dosage
  • Phacoemulsification*
  • Prednisolone / administration & dosage*
  • Prednisolone / analogs & derivatives*
  • Prospective Studies
  • Pupil / drug effects*

Substances

  • Cyclooxygenase Inhibitors
  • Glucocorticoids
  • Mydriatics
  • Ophthalmic Solutions
  • Flurbiprofen
  • prednisolone acetate
  • Prednisolone